Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
The Fate of Gaming: 5 Energizing Advancements Not too far off - 2Japan prepares to restart world's biggest nuclear plant, 15 years after Fukushima
- 3Some gifted dogs can learn new toy names by eavesdropping on owners
- 4Novo Nordisk slashes prices of popular weight loss and diabetes drugs
- 5What is a Trump Gold Card? U.S. launches $1 million immigration visas
- More loons are filling Maine's lakes with their ghostlike calls
- The Best Design Bloggers for Style Motivation
- 4 Excellent Remote Headphones of 2024
- Vote In favor of Your Favored IT Administration
- Step by step instructions to Lessen Your Gamble of Creating Cellular breakdown in the lungs
- Rick Steves' Newest Guidebook Is A Fresh Perspective On Italy Spilling The Country's Secrets
- Investigating the Financial History of the World: A Succinct Outline
- Bayer reports positive results for blood thinner after 2023 setback
- Sydney Sweeney is returning in 'The Housemaid's Secret': What to know about 'The Housemaid' sequel
